Literature DB >> 10805519

A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy.

P Ylikangas1, I Mononen.   

Abstract

The antineoplastic enzyme L-asparaginase is commonly used for the induction of remission in acute lymphoblastic leukemia (ALL). There is no simple method available for measuring the activity of this highly toxic drug. We incubated L-asparaginase from Erwinia chrysanthemi with L-aspartic acid beta-(7-amido-4-methylcoumarin) and measured the release of 7-amino-4-methylcoumarin fluorometrically for 30-300 min. The rate of the hydrolysis of the substrate was linear over a 50-fold range of the concentration of the enzyme. With increasing substrate concentration, the enzyme showed a saturable kinetic pattern with V(max) of 0.547 (SD 0.059) microM/min/mg of enzyme (n = 3) and Km of 0.302 (SD 0.095) mM (n = 3). This assay enables rapid analysis of L-asparaginase activity in biological samples and it can be used, for example, for monitoring of L-asparaginase activity in serum of ALL patients during their L-asparaginase therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805519     DOI: 10.1006/abio.2000.4500

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

1.  Enzyme-mediated individual nanoparticle release assay.

Authors:  James R Glass; Janet C Dickerson; David A Schultz
Journal:  Anal Biochem       Date:  2006-03-31       Impact factor: 3.365

Review 2.  Overview of the structure, side effects, and activity assays of l-asparaginase as a therapy drug of acute lymphoblastic leukemia.

Authors:  Nanxiang Wang; Wenhui Ji; Lan Wang; Wanxia Wu; Wei Zhang; Qiong Wu; Wei Du; Hua Bai; Bo Peng; Bo Ma; Lin Li
Journal:  RSC Med Chem       Date:  2022-01-12

3.  High-throughput asparaginase activity assay in serum of children with leukemia.

Authors:  Christian A Fernandez; Xiangjun Cai; Allie Elozory; Chengcheng Liu; J Carl Panetta; Sima Jeha; Alejandro R Molinelli; Mary V Relling
Journal:  Int J Clin Exp Med       Date:  2013-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.